Published in Gene Therapy Weekly, July 27th, 1998
To enhance the efficacy of DNA malaria vaccines, Martha Sedegah and colleagues from the Naval Medical Research Institute, Maryland, the University of Maryland School of Medicine, Vical, Inc., California, and Virogenetics Corporation, New York, evaluated the protective effect of immunizing with various combinations of DNA, recombinant vaccinia virus, and a synthetic peptide ("Boosting with Recombinant Vaccinia Increases Immunogenicity and Protective Efficacy of Malaria DNA Vaccine," Proceedings of the National...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.